Smart Quotes
Glaxosmithkline Pharmaceuticals Ltd.
BSE CODE: 500660   |   NSE CODE: GLAXO   |   ISIN CODE : INE159A01016
BSE NSE
2661.05
-5.35 ( -0.2% )
 
Prev Close ( Rs.)
2666.40
Open ( Rs.)
2678.20
 
High ( Rs.)
2691.95
Low ( Rs.)
2660.85
 
Volume
209
Week Avg.Volume
1942
 
52 WK High-Low Range (Rs.)
BSE NSE
2661.50
-5.95 ( -0.22% )
 
Prev Close ( Rs.)
2667.45
Open ( Rs.)
2679.00
 
High ( Rs.)
2679.00
Low ( Rs.)
2659.00
 
Volume
2450
Week Avg.Volume
7252
 
52 WK High-Low Range (Rs.)
2600
3872
1D   | 1M   | 3M   | 1Y  | 3Y  | 5Y
You need to upgrade your Flash Player
F&O Quote of GLAXO
Instrument Type Expiry Date Option Type Strike Price
  QUOTES  
Rs.     ()
Open (Rs.)
Prev Close (Rs.)
High (Rs.)
Low (Rs.)
Average Price Rs.
Contracts Traded
Turnover (Rs.Lakhs)
Open Interest 
Open Int. Chg 
Open Int. Chg(%)
Competitors
Company NameLast Price (Rs.)Chg (Rs./%)Sales TurnOverVolume
Alkem Laboratories2160.0086.15(4.15)297.7718220.00
Sanofi India4185.3546.70(1.13)706.4332.00
Torrent Pharma1328.0032.45(2.50)217.8010066.00
NGL Fine-Chem370.0026.55(7.73)71.5724937.00
Ajanta Pharma1728.9525.40(1.49)127.785403.00
More>
KEY PERSONNEL & ADDRESS
Chairman
D S Parekh
Managing Director
Annaswamy Vaidheesh
Company Secretary
AA Nadkarni
Executive Director
Andrew Aristidou
R Krishnaswamy
Registered Office :
Dr Annie Besant Road,Worli,, Mumbai,
Maharashtra-400030 .
Phone :
022-24959595  
E-mail :
askus@gsk.com
URL
www.gsk-india.com
 
News On GLAXO
13/02/2017
GlaxoSmithKline Pharma reports...
19/01/2017
GlaxoSmithKline Pharmaceutical...
19/01/2017
Q3 results on Feb 11, 2017
27/12/2016
General Announcement
More >
Financials
QUARTERLY (Dec 16)
Net Profit( Rs . In Mn) 529.5
Gross Profit( Rs . In Mn) 781.6
Operating Profit( Rs . In Mn) 668.8
Net Sales( Rs .In Mn) 7063.8
More>
MF Holding Details
Scheme NameMkt value (In Cr.)
Birla SL MNC Fund(G)186.06
Birla SL Tax Relief '96(ELSS U/S 80C of ...74.07
Birla SL Frontline Equity Fund(G)48.32
UTI MNC Fund(D)43.74
UTI Dividend Yield Fund(G)17.20
Birla SL Tax Plan(D)12.52
IDBI Diversified Equity Fund(G)7.82
More>